ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 3 • 2016 ACR/ARHP Annual Meeting

    The Presence of Rheumatoid Factor Is Associated with Lower Bone Mass in Korean Health Screening Male Subjects without Clinically Apparent Arthritis

    Jiwon Hwang1, Joong Kyong Ahn2, Yeonghee Eun3, Hyemin Jeong3, Eun-Jung Park4, Hyungjin Kim3, Jaejoon Lee3, Eun-Mi Koh3 and Hoon-Suk Cha5, 1Department of Medicine, National Police Hospital, Seoul, Korea, The Republic of, 2Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, 3Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 4Department of Medicine, Division of Rheumatology, Department of Medicine, Jeju National University Hospital, Jeju University School of Medicine, Jeju, South Korea, 5Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

    Background/Purpose:  Close relationship between the immune and skeletal systems has been recognized through the bone loss in rheumatoid arthritis (RA). Rheumatoid factor (RF) is present…
  • Abstract Number: 4 • 2016 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis (RA)-Related Joint Symptoms and Thoracic Bone Mineral Density in an RA-Free Community Dwelling Population

    Jan M. Hughes-Austin1, Joachim H. Ix2, Samuel R. Ward3, M. Kristen Demoruelle4, V. Michael Holers5, Jill M. Norris6 and Kevin D. Deane7, 1Orthopaedic Surgery, University of California, San Diego, La Jolla, CA, 2University of California, San Diego, La Jolla, CA, 3Radiology, Orthopaedic Surgery, and Bioengineering, University of California, San Diego, La Jolla, CA, 41775 Aurora Ct, 1775 Aurora Ct, Aurora, CO, 5Rheumatology Division, University of Colorado School of Medicine, Aurora, CO, 6University of Colorado Denver, Aurora, CO, 7Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Osteoporosis, defined by Tscore < -2.5, is one of the main consequences of RA and it appears early in the disease. It is twice…
  • Abstract Number: 5 • 2016 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis and Periodontitis: Association and Characteristics of Chronic Periodontitis

    BEATRIZ RODRIGUEZ-LOZANO1, Jerián González Febles2, Jorge Luis Garnier Rodríguez3, Shashi Dadlani4, Elisa Trujillo-Martin1, Vanesa Hernández Hernández1, Sagrario Bustabad5, Mariano Sanz Alonso2 and Federico Díaz-González1, 1Rheumatology, Hospital Universitario de Canarias, S/C Tenerife, Spain, 2Periodontology, Universidad Complutense de Madrid, Madrid, Spain, 3Odontology, Dental Clinic Garnier, S/C Tenerife, Spain, 4Periodontology, Dental Clinic Garnier, S/C Tenerife, Spain, 5Rheumatology, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain

    Background/Purpose: Recent clinical-epidemiological data suggest that periodontitis (P) shows higher prevalence in rheumatoid arthritis (RA) patients. However, due to the scarcity of epidemiological studies, the…
  • Abstract Number: 6 • 2016 ACR/ARHP Annual Meeting

    Lower Omega-3 Fatty Acid Biomarkers Are Associated with Inflammatory Arthritis in a Population Positive for Anti-Citrullinated Protein Antibodies

    Ryan W. Gan1, Elizabeth A. Bemis1, M. Kristen Demoruelle2, Kevin D. Deane2, Christopher C. Striebich3, James H. Goddard4, Stacey A. Brake4, Michael J. Clare-Salzler5, V. Michael Holers6 and Jill M. Norris1, 1Epidemiology, Colorado School of Public Health, Aurora, CO, 2Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 3Division of Rhuematology, University of Colorado School of Medicine, Aurora, CO, 4Nine Health Services, Inc., Denver, CO, 5Experimental Pathology, University of Florida, College of Medicine, Gainesville, FL, 6Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Antibodies to citrullinated protein antigens (ACPA) can be elevated prior to onset of inflammatory arthritis (IA) and RA. However, understanding of factors related to…
  • Abstract Number: 7 • 2016 ACR/ARHP Annual Meeting

    Long-Term Dietary Changes after Rheumatoid Arthritis Diagnosis in Swedish Women: Data from a Population Based Cohort

    Cecilia Lourdudoss1, Alicja Wolk2, Laurent Arnaud1, Ronald van Vollenhoven1 and Daniela Di Giuseppe3, 1Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), Dept. of Medicine, Karolinska institutet, Stockholm, Sweden, 2Unit of Nutritional Epidemiology, Dept of Environmental Medicine, Karolinska institutet, Stockholm, Sweden, 3Clinical Epidemiology Unit, Dept. of Medicine, K2, Karolinska institutet, Stockholm, Sweden

    Background/Purpose: The interest of dietary factors in rheumatoid arthritis (RA) has increased among researchers and RA patients over the last decade. Although several interventions as…
  • Abstract Number: 8 • 2016 ACR/ARHP Annual Meeting

    What Factors Relate to Patients Contributing Longitudinal Data Using Smartphone Technology? Findings from RA Patients Participating in Arthritispower Registry

    Huifeng Yun1, W. Ben Nowell2, James Willig3, Jennifer Beaumont4, Bernadette Johnson5, Seth D. Ginsberg6, Carole Wiedmeyer2, Rachelle Crow-Hercher7, Britt J. Johnson7, Shuo Yang8 and Jeffrey Curtis9, 1Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, 2CreakyJoints/Global Health Living Foundation, Upper Nyack, NY, 3Med - Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, 4Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 6Global Healthy Living Foundation, CreakyJoints, Upper Nyack, NY, 7Global Healthy Living Foundation, Upper Nyack, NY, 8Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 9Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Data capture of patient reported outcomes (PROs) is gradually shifting from data collection on paper in medical office to use of computer or mobile…
  • Abstract Number: 9 • 2016 ACR/ARHP Annual Meeting

    Effects of Alcohol Consumption on the Severity of Inflammation in Hand and Foot Joints Detected with MR Imaging

    L. Mangnus1, M. Reijnierse2 and A.H.M. van der Helm- van Mil3, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, Leiden University Medical Center, Leiden, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Moderate alcohol consumption is associated with a lower risk on RA development. (1,2) It is also associated with less severe systemic inflammation. Based on these…
  • Abstract Number: 10 • 2016 ACR/ARHP Annual Meeting

    The Utility of Screening for Infectious Diseases in Recipients of Anti-TNF-α Therapy

    Kristal Choi1, Lester Mertz2, Russell Heigh3, James Yiannias4 and Janis Blair5, 1Internal Medicine, Mayo Clinic Arizona, Scottsdale, AZ, 2Rheumatology, Mayo Clinic Arizona, Scottsdale, AZ, 3Gastroenterology, Mayo Clinic Arizona, Scottsdale, AZ, 4Dermatology, Mayo Clinic Arizona, Scottsdale, AZ, 5Infectious Diseases, Mayo Clinic Arizona, Scottsdale, AZ

    The Utility of Screening for Infectious Diseases in Recipients of Anti-TNF-α Therapy   Choi, Kristal, Mertz, Lester, Heigh, Russell, Yiannias, James, Blair, Janis Background/Purpose: Tumor…
  • Abstract Number: 11 • 2016 ACR/ARHP Annual Meeting

    Drug Prescribing Trends in Adults with Rheumatoid Arthritis: A Population-Based Comparative Study from 2005-2014

    Alex Zamora-Legoff1, Cynthia S. Crowson2, Eric L. Matteson3, Sara J. Achenbach4 and Elena Myasoedova3, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic, Rochester, MN, 3Rheumatology, Mayo Clinic, Rochester, MN, 4Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose:  To examine drug prescribing trends for patients with rheumatoid arthritis (RA) over recent years and compare them to matched non-RA subjects. Methods: Retrospective prescription…
  • Abstract Number: 12 • 2016 ACR/ARHP Annual Meeting

    Benefit of Early Therapy with Methotrexate and Prednisone in Patients with Early Rheumatoid Arthritis and Undifferentiated Early Arthritis (CONAART)

    Soledad Retamozo1, Maria Jezabel Haye Salinas2, Juan Pablo Pirola3, Diego Baenas2, Ana C. Alvarez4, Veronica Saurit3, Alejandro Alvarellos5, Christian A. Waimann6, Gustavo Citera7,8, Fernando Dal Pra9, Celeste Orozco9, Federico Ceccato10, Sergio Paira10, MV Martire11, G Crespo Amaya11, Anastasia Secco11, M Mamani11, Javier Rosa12, Enrique Soriano12, Josefina Marcos13, Mercedes Argentina García14, Carolina Costi15, María M Zalazar16, Alejandro Martinez Muñoz16, Oscar Luis Rillo17, Horacio Berman18, Alberto Berman18, Francisco Colombres18, Edson Javier Velozo19, Vicente Ricardo Juarez20, M Crespo20, A Quinteros21, M Leal21, G Salvatierra22, Monica Sacnún23, R Quintana23, M Abdala24 and Francisco Caeiro25, 1Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Argentina, Córdoba, Argentina, 2Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, 3Rheumatology, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, 4Hospital Privado Centro Medico de Cordoba, Cordoba, Argentina, 5Rheumatology, Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina, 6Escuela Superior de Ciencias de la Salud, UNICEN., Olavarria,, Argentina, 7Rheumatology, Instituto de Rehabilitacion Psicofisica - Fundacion Reumatologica Argentina Dr. Osvaldo Garcia-Morteo, Buenos Aires, Argentina, 8Rheumatology, CONAART - IREP, Buenos Aires, Argentina, 9Instituto De Rehabilitación Psicofísica, Argentina, CABA, Argentina, 10Hospital Dr José María Cullen, Santa Fe, Argentina, 11Hospital Bernardino Rivadavia, CABA, Argentina, 12Hospital Italiano De Buenos Aires, CABA, Argentina, 13Hospital San Martin, La Plata, Argentina, 14Rheumatology Unit, HIGA San Martín La Plata, La Plata, Argentina, 15Hospital San Martín, LaPlata, Argentina, 16Hospital Pirovano, CABA, Argentina, 17Rheumatology Department, Hospital General de Agudos “Dr. Ignacio Pirovano”, Buenos Aires, Argentina, Buenos Aires, Argentina, 18Centro Médico Privado De Reumatología (Tucumán), Tucumán, Argentina, 19Rheumatology, Sanatorio Adventista del Plata, Entre Rios, Argentina, 20Hospital Señor Del Milagro, Salta, Argentina, 21Centro Integral De Reumatología, Tucumán, Argentina, 22Instituto Provincial De Rehabilitación Integral, Santiago del Estero, Argentina, 23Hospital Provincial De Rosario, Rosario, Argentina, 24Hospital Provincial Del Centenario, Rosario, Argentina, 25Rheumatology, Hospital Privado Centro Medico De Córdoba, Cordoba, Argentina

    Background/Purpose: To analyze clinical remission in patients with early RA and undifferentiated arthritis (UA) during the first 2 years of treatment using methotrexate (MTX) and…
  • Abstract Number: 13 • 2016 ACR/ARHP Annual Meeting

    Genetic Variants of the Vasoactive Intestinal Peptide (VIP) Gen in Association with Rheumatoid Arthritis Treatment Requirements

    Iria V. Seoane1, Carmen Martinez2, Yasmina Juarranz1, Rosario García-Vicuña3, Eva Tomero4, Rosa P Gomariz1, Isidoro Gonzalez-Alvaro3 and Amalia Lamana5, 1Cellular Biology, School of Biology. Universidad Complutense de Madrid, Madrid, Spain, 2Cellular Biology, School of Medicine. Universidad Complutense de Madrid, Madrid, Spain, 3Rheumatology, Rheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 4Rheumatology, Hospital Universitario de la Princesa, Madrid, Spain, 5Rheumatology, Hospital Universitario de La Princesa. IIS Princesa, Madrid, Spain

    Background/Purpose: Biomarkers to recognize patients with a more intensive therapy necessity in rheumatoid arthritis are essential and scarce. VIP has shown immunoregulatory properties both in…
  • Abstract Number: 14 • 2016 ACR/ARHP Annual Meeting

    Failure Predictors to Anti-Tumor Necrosis Antagonists in Patients with Chronic Arthritis: Results of a National Registry Biobadasar

    Maria Jezabel Haye Salinas1, Soledad Retamozo2, Alejandro Alvarellos3, Francisco Caeiro4, Juan Pablo Pirola4, Diego Baenas1, María Celina de La Vega5, Gustavo Casado6, Gimena Gomez7, Javier Roberti8, Osvaldo Luis Cerda9, Ignacio Javier Gandino10, Ana Quinteros11, Ida Exeni6,12, Juan Manuel Bande13, Juan Carlos Barreira14, Carla Gobbi15, Analia Alvarez16, Amelia Granel17, Alejandra Peluzzon18, Ana Capuccio19, Romina Nieto20, Rossana Quintana21, Eduardo Mussano22, Santiago Scarafia23, Carolina Costi24, Mercedes De La Sota25, Monica Patricia Diaz26, Edson Javier Velozo27, Santiago Aguero28, Cristina Battagliotti29, Sidney Soares de Souza30, Emilia Cavillon31, Analia Bohr32, Andrea Smichowski33, Daniela Vidal34, Dora Pereira35, Liliana Martinez36, Luis Somma37, Marta Zalazar38, Pablo Finucci Curi39, Leandro Carlevaris40, Guillermo Berbotto41 and Veronica Saurit4, 1Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, 2Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Argentina, Córdoba, Argentina, 3Rheumatology, Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina, 4Rheumatology, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, 5Sociedad Argentina de Reumatología, CABA, Argentina, 6Sociedad Argentina de Reumatologia, CABA, Argentina, 7Sociedad Argentina de Reumatología, Buenos Aires, Argentina, 8SAR, CABA, Argentina, 9IREP, CABA, Argentina, 10Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 11Centro Integral Reumatológico, Tucuman, Argentina, 12Sanatorio Parque, Cordoba, Argentina, 13Hospital Tornú, CABA, Argentina, 14Rheumatology Unit, Hospital Britanico de Buenos Aires, CABA, Argentina, 15Rheumatology, Sanatorio Allende de Córdoba, Cordoba, Argentina, 16Hospital Penna, Bahía Blanca, Argentina, 17Centro Platense de Reumatología, La Plata, Argentina, 18Hospital Clínica José de San Martín, CABA, Argentina, 19Hospital Cesar Milstein, CABA, Argentina, 20Hospital Provincial, Rosario, Argentina, 21Sanatorio Parque, Rosario, Argentina, 22Córdoba, Hospital Nacional de Clínicas, Córdoba, Argentina, 23Hospital Bernardino Rivadavia, CABA, Argentina, 24Hospital San Martín, LaPlata, Argentina, 25Consultorios, Bahia Blanca, Argentina, 26Hospital Zonal Bariloche, Bariloche, Argentina, 27Rheumatology, Sanatorio Adventista del Plata, Entre Rios, Argentina, 28Sanatorio Pasteur, Catamarca, Argentina, 29Hospital de Niños Dr Orlando Alasia, Santa Fé, Argentina, 30Ramallo 1851, REUMAR, CABA, Argentina, 31Consultorio, Cordoba, Argentina, 32Hospital de Rehabilitación Rocca, CABA, Argentina, 33Atención Integral de Reumatología, CABA, Argentina, 34Hospital de Niños de Córdoba, Córdoba, Argentina, 35Centro Raquis, Buenos Aires, Argentina, 36Hospital Fernandez, CABA, Argentina, 37SOMMA, Buenos Aires, Argentina, 38Hospital Pirovano, CABA, Argentina, 39Centro Médico Mitre, Entre Rios, Argentina, 40IARI, CABA, Argentina, 41Sanatorio Británico, Rosario, Argentina

    Background/Purpose: to analyze failure predictors to anti-tumor necrosis (TNF) therapy in patients who have switched these drugs during chronic arthritis treatment. Methods: BIOBADASAR is a…
  • Abstract Number: 15 • 2016 ACR/ARHP Annual Meeting

    Adverse Events and Persistency of Biologics in Rheumatoid Arthritis Patients with Interstitial Lung Disease

    Dam Kim1, Soo-Kyung Cho2, Soyoung Won3, Hoon-Suk Cha4, Chan-Bum Choi5, Seung-Jae Hong6, Jisoo Lee7, Dong-Hyuk Sheen8, Dae-Hyun Yoo9, Sang-Cheol Bae10 and Yoon-Kyoung Sung1, 1Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 2Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, The Republic of, 3Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 4Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 5Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 6Dept. of Rheumatology, #1 Hoeg, KyungHee University Medical Center, SEOUL, South Korea, 7Int Medicine, Ewha Woman's Univ Schl of Med, Seoul, Korea, Republic of, 8Division of Rheumatology, Eulji University, Daejeon, Korea, The Republic of, 9Division of Rheumatology, Department of Internal Medicine, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 10Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, Korea, The Republic of

    Background/Purpose:  RA associated ILD (RA-ILD) is reported as 1-58% depending on the study population and the definition of ILD, and RA-ILD is known to be…
  • Abstract Number: 16 • 2016 ACR/ARHP Annual Meeting

    Differences Between Patient and Physician Global Assessment on Rheumatoid Arthritis Disease Activity Status in High and Lower Income  Countries Contribute to Inequity

    SA Bergstra1, R van den Berg1, A Chopra2, JAP da Silva3, D Vega-Morales4, N Govind5, TWJ Huizinga6 and RBM Landewé7,8, 1Department of Rheumatology, LUMC, Leiden, Netherlands, Leiden, Netherlands, 2Department of Rheumatology, Center for Rheumatic Diseases, Pune, India, Pune, India, 3Department of Rheumatology, SRHUC, Coimbra, Portugal, Coimbra, Portugal, 4Universidad Autónoma de Nuevo Léon, Monterrey, Mexico, Monterrey, Mexico, 5Department of Rheumatology, University of the Witwatersrand, Johannesburg, South Africa, Johannesburg, South Africa, 6Leiden University Medical Centre, Leiden, Netherlands, 7Amsterdam Rheumatology & Immunology Center, Netherlands, Amsterdam, Netherlands, 8Zuyderland Medical Center, Heerlen, Netherlands, Heerlen, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) patients score their global disease activity (ptGD) on average higher than physicians (phGD). This difference can vary between countries with high…
  • Abstract Number: 17 • 2016 ACR/ARHP Annual Meeting

    The Importance of Achieving Clinical Response to Treatment and Changes in Physical Ability and Quality of Life on Worker Productivity Outcomes in Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register

    Sarah Leggett1, Kimme L. Hyrich1,2, Mark Lunt1, Karen Walker-Bone3 and Suzanne M.M. Verstappen1, 1Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, 2Arthritis Research UK, Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, United Kingdom, 3University of Southampton, Arthritis Research UK / MRC Centre for Musculoskeletal Health and Work, Southampton, United Kingdom

    Background/Purpose: It is well known that patients with RA experience health-related job loss, more days absent from work (i.e., absenteeism), and to a greater extent,…
  • « Previous Page
  • 1
  • …
  • 1417
  • 1418
  • 1419
  • 1420
  • 1421
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology